Nutrition bribe: supplements may boost measles shots in nigeria
NCT ID NCT06387511
First seen Nov 01, 2025 · Last updated Jun 22, 2026 · Updated 29 times
Summary
This study tested whether providing monthly nutritional supplements (SQ-LNS) to children aged 6-23 months could encourage families to get them vaccinated against measles. Over 3,800 children in northern Nigeria took part. The goal was to see if the supplement program, offered at health centers, would increase the number of children receiving the measles vaccine compared to standard care alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
All Primary Health Care Centers of Nguru and Karasuwa LGAs
Damaturu, Yobe State, Nigeria
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
small-quantity lipid-based nutrition supplements (SQ-LNS)
What this could lead to
If it works, this approach could offer a simple, low-cost way to boost measles vaccination coverage in underserved communities.
What could go wrong
This is a completed trial in a specific region of Nigeria, so results may not apply elsewhere. The study tested a strategy, not a new vaccine or cure.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.